Doctors' views on the quality of claims provided by pharmaceutical representatives

A comparative study in Malaysia and Australia

Noordin Othman, Agnes I. Vitry, Elizabeth E. Roughead, Shaiful Bahari Ismail, Khairani Omar

Research output: Contribution to journalArticle

Abstract

Objectives: Doctors perceive the interactions with pharmaceutical representatives as professionally appropriate. However, studies have shown that the interaction is associated with less rational prescribing of medications. No previous study has assessed doctors' opinions of the presentation of pharmaceutical representatives and the quality of claims provided to the doctors in Australia and Malaysia. The aim of this study was to compare the opinions of Australian and Malaysian doctors of sales explanations and quality of claims provided by the pharmaceutical representatives. Materials and Methods: We recruited samples of primary care doctors in Australia and Malaysia to evaluate pharmaceutical sales visits. After a visit, doctors were asked to fill out a questionnaire on the main product and claims discussed during the visit. Descriptive statistics were employed, and Chi-square analysis and clustered linear regression were used to assess differences between doctors from both countries. Results: The majority of doctors reported that the presentations were convincing as well as likely to change their prescribing habits and improved their knowledge. The majority of marketing claims recorded by doctors in Australia and Malaysia were classified as vague claims. Approximately one-third of the claims were unambiguous (Australia 31% and Malaysia 33%). In a majority of the presentations (Australia, 65%, Malaysia, 84%), doctors indicated that the primary claims by the pharmaceutical representatives were entirely or nearly accurate. Conclusions: Doctors in Australia and Malaysia held generally positive views of the presentations of pharmaceutical representatives, although the information being presented varied.

Original languageEnglish
JournalJournal of Taibah University Medical Sciences
DOIs
Publication statusAccepted/In press - 20 Dec 2014

Fingerprint

Malaysia
Pharmaceutical Preparations
Marketing
Habits
Linear Models
Primary Health Care

Keywords

  • Australia
  • Claims
  • Malaysia
  • Pharmaceutical representatives
  • Promotion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Doctors' views on the quality of claims provided by pharmaceutical representatives : A comparative study in Malaysia and Australia. / Othman, Noordin; Vitry, Agnes I.; Roughead, Elizabeth E.; Ismail, Shaiful Bahari; Omar, Khairani.

In: Journal of Taibah University Medical Sciences, 20.12.2014.

Research output: Contribution to journalArticle

Othman, Noordin ; Vitry, Agnes I. ; Roughead, Elizabeth E. ; Ismail, Shaiful Bahari ; Omar, Khairani. / Doctors' views on the quality of claims provided by pharmaceutical representatives : A comparative study in Malaysia and Australia. In: Journal of Taibah University Medical Sciences. 2014.
@article{ad2403d22fdf450abdfc4732a3d39f2a,
title = "Doctors' views on the quality of claims provided by pharmaceutical representatives: A comparative study in Malaysia and Australia",
abstract = "Objectives: Doctors perceive the interactions with pharmaceutical representatives as professionally appropriate. However, studies have shown that the interaction is associated with less rational prescribing of medications. No previous study has assessed doctors' opinions of the presentation of pharmaceutical representatives and the quality of claims provided to the doctors in Australia and Malaysia. The aim of this study was to compare the opinions of Australian and Malaysian doctors of sales explanations and quality of claims provided by the pharmaceutical representatives. Materials and Methods: We recruited samples of primary care doctors in Australia and Malaysia to evaluate pharmaceutical sales visits. After a visit, doctors were asked to fill out a questionnaire on the main product and claims discussed during the visit. Descriptive statistics were employed, and Chi-square analysis and clustered linear regression were used to assess differences between doctors from both countries. Results: The majority of doctors reported that the presentations were convincing as well as likely to change their prescribing habits and improved their knowledge. The majority of marketing claims recorded by doctors in Australia and Malaysia were classified as vague claims. Approximately one-third of the claims were unambiguous (Australia 31{\%} and Malaysia 33{\%}). In a majority of the presentations (Australia, 65{\%}, Malaysia, 84{\%}), doctors indicated that the primary claims by the pharmaceutical representatives were entirely or nearly accurate. Conclusions: Doctors in Australia and Malaysia held generally positive views of the presentations of pharmaceutical representatives, although the information being presented varied.",
keywords = "Australia, Claims, Malaysia, Pharmaceutical representatives, Promotion",
author = "Noordin Othman and Vitry, {Agnes I.} and Roughead, {Elizabeth E.} and Ismail, {Shaiful Bahari} and Khairani Omar",
year = "2014",
month = "12",
day = "20",
doi = "10.1016/j.jtumed.2015.03.002",
language = "English",
journal = "Journal of Taibah University Medical Sciences",
issn = "1658-3612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Doctors' views on the quality of claims provided by pharmaceutical representatives

T2 - A comparative study in Malaysia and Australia

AU - Othman, Noordin

AU - Vitry, Agnes I.

AU - Roughead, Elizabeth E.

AU - Ismail, Shaiful Bahari

AU - Omar, Khairani

PY - 2014/12/20

Y1 - 2014/12/20

N2 - Objectives: Doctors perceive the interactions with pharmaceutical representatives as professionally appropriate. However, studies have shown that the interaction is associated with less rational prescribing of medications. No previous study has assessed doctors' opinions of the presentation of pharmaceutical representatives and the quality of claims provided to the doctors in Australia and Malaysia. The aim of this study was to compare the opinions of Australian and Malaysian doctors of sales explanations and quality of claims provided by the pharmaceutical representatives. Materials and Methods: We recruited samples of primary care doctors in Australia and Malaysia to evaluate pharmaceutical sales visits. After a visit, doctors were asked to fill out a questionnaire on the main product and claims discussed during the visit. Descriptive statistics were employed, and Chi-square analysis and clustered linear regression were used to assess differences between doctors from both countries. Results: The majority of doctors reported that the presentations were convincing as well as likely to change their prescribing habits and improved their knowledge. The majority of marketing claims recorded by doctors in Australia and Malaysia were classified as vague claims. Approximately one-third of the claims were unambiguous (Australia 31% and Malaysia 33%). In a majority of the presentations (Australia, 65%, Malaysia, 84%), doctors indicated that the primary claims by the pharmaceutical representatives were entirely or nearly accurate. Conclusions: Doctors in Australia and Malaysia held generally positive views of the presentations of pharmaceutical representatives, although the information being presented varied.

AB - Objectives: Doctors perceive the interactions with pharmaceutical representatives as professionally appropriate. However, studies have shown that the interaction is associated with less rational prescribing of medications. No previous study has assessed doctors' opinions of the presentation of pharmaceutical representatives and the quality of claims provided to the doctors in Australia and Malaysia. The aim of this study was to compare the opinions of Australian and Malaysian doctors of sales explanations and quality of claims provided by the pharmaceutical representatives. Materials and Methods: We recruited samples of primary care doctors in Australia and Malaysia to evaluate pharmaceutical sales visits. After a visit, doctors were asked to fill out a questionnaire on the main product and claims discussed during the visit. Descriptive statistics were employed, and Chi-square analysis and clustered linear regression were used to assess differences between doctors from both countries. Results: The majority of doctors reported that the presentations were convincing as well as likely to change their prescribing habits and improved their knowledge. The majority of marketing claims recorded by doctors in Australia and Malaysia were classified as vague claims. Approximately one-third of the claims were unambiguous (Australia 31% and Malaysia 33%). In a majority of the presentations (Australia, 65%, Malaysia, 84%), doctors indicated that the primary claims by the pharmaceutical representatives were entirely or nearly accurate. Conclusions: Doctors in Australia and Malaysia held generally positive views of the presentations of pharmaceutical representatives, although the information being presented varied.

KW - Australia

KW - Claims

KW - Malaysia

KW - Pharmaceutical representatives

KW - Promotion

UR - http://www.scopus.com/inward/record.url?scp=84946169108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946169108&partnerID=8YFLogxK

U2 - 10.1016/j.jtumed.2015.03.002

DO - 10.1016/j.jtumed.2015.03.002

M3 - Article

JO - Journal of Taibah University Medical Sciences

JF - Journal of Taibah University Medical Sciences

SN - 1658-3612

ER -